POTENTIAL ANTILEPROTIC AGENTS .1. INHIBITION OF A MODEL MYCOBACTERIAL SYSTEM BY DIARYL SULFONES

被引：29

作者：

COLWELL, WT

CHAN, G

BROWN, VH

DEGRAW, JI

PETERS, JH

MORRISON, NE

机构：

[1] STANFORD RES INST,MENLO PK,CA 94025

[2] JOHNS HOPKINS UNIV,LEONARD WOOD MEM LAB,BALTIMORE,MD 21205

[3] PHS HOSP,SAN FRANCISCO,CA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1974年 / 17卷 / 01期

关键词：

D O I：

10.1021/jm00247a031

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：142 / 144

页数：3

共 10 条

[1]

ANAND N, 1953, J SCI IND RES B, V12, P353

[2]

Brown G M, 1967, Int J Lepr Other Mycobact Dis, V35, P580

[3]

DOUB L, 1961, MEDICINAL CHEMISTRY, V5

[4] REPOSITORY DRUGS .4. 4',4'''-SULFONYLBISACETANILIDE(ACEDAPSONE,DADDS) AND RELATED SULFANILYLANILIDES WITH PROLONGED ANTIMALARIAL AND ANTILEPROTIC ACTION [J].

ELSLAGER, EF ;

GAVRILIS, ZB ;

PHILLIPS, AA ;

WORTH, DF .

JOURNAL OF MEDICINAL CHEMISTRY, 1969, 12 (03) :357-&

[5]

HITCHINGS GEORGE H., 1965, ADVANCE ENZYMOL, V27, P417

[6] INHIBITION OF DIHYDROPTEROATE SYNTHETASE FROM ESCHERICHIA-COLI BY SULFONES AND SULFONAMIDES [J].

MCCULLOUGH, JL ;

MAREN, TH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (06) :665-669

[7]

MORRISON N E, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P34

[8]

NODZU R, 1955, NIPPON KAGAKU ZASSHI, V76, P775

[9] THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE [J].

SHEPARD, CC .

JOURNAL OF EXPERIMENTAL MEDICINE, 1960, 112 (03) :445-&

[10] CHEMOTHERAPY OF LEPROSY [J].

SHEPARD, CC .

ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :37-+

← 1 →